PECAM1 and Alzheimer disease: When CD31 fluorescence was examined, its overlap with HS fluorescence significantly increased in AD patients compared to control subjects (control mean = 0.4326, AD mean = 0.51, Z = −2.28, p = 0.001) (Figure 2D), indicating that more ECs express or are covered with above-background HS in AD.